✦ LIBER ✦
Post-transplant outcomes of induction therapy for myeloma: Thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support
✍ Scribed by Dan T. Vogl; Stephen V. Liu; Elise A. Chong; Selina M. Luger; David L. Porter; Stephen J. Schuster; Donald E. Tsai; Alexander Perl; Alison W. Loren; Steven C. Goldstein; Sunita D. Nasta; Charalambos Andreadis; Patricia A. Mangan; Kimberly Hummel; Don L. Siegel; Eli Glatstein; Edward A. Stadtmauer
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 159 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.